Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.53 |
| ▸ | MYC | P01106 | 2/20 | 0.53 |
| ▸ | ESR1 | P03372 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | CA4 | P22748 | 2/20 | 0.46 |
| ▸ | CA6 | P23280 | 2/20 | 0.46 |
| ▸ | CA7 | P43166 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27830208 | 0.86 | HTT (0.53) | TSHRMYCESR1ALOX15PTPN7 | |
| SCHEMBL860172 | 0.84 | CYP2A6 (0.47) | TSHRMYCESR1ALOX15PTPN7 | |
| SCHEMBL2952250 | 0.84 | TSHR (0.52) | TSHRMYCESR1ALOX15PTPN7 | |
| SCHEMBL27461218 | 0.83 | TSHR (0.38) | TSHRMYCESR1ALOX15PTPN7 | |
| SCHEMBL6516135 | 0.83 | CYP2A6 (0.46) | TSHRMYCESR1ALOX15PTPN7 | |
| SCHEMBL6519005 | 0.83 | CYP2A6 (0.46) | TSHRMYCESR1ALOX15PTPN7 | |
| SCHEMBL6519001 | 0.83 | CYP2A6 (0.46) | TSHRMYCESR1ALOX15PTPN7 | |
| SCHEMBL8404521 | 0.83 | PARP1 (0.48) | TSHRHSD17B10GRM1TDP1MEN1 | |
| SCHEMBL310259 | 0.81 | CES2 (0.63) | TSHRMYCESR1ALOX15PTPN7 | |
| SCHEMBL29421064 | 0.81 | CES2 (0.63) | TSHRMYCESR1ALOX15PTPN7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3859804-B1 | SEMICONDUCTOR DEVICE HAVING QUANTUM DOTS | CANON KK (JP) | 2024-08-07 | — | — | EP | claimed |
| CN-101309922-A | Amino-aza-adamantane derivatives and methods of use | ABBOTT LAB (US) | 2008-11-19 | — | — | CN | claimed |
| US-12245446-B2 | Semiconductor device having quantum dots, display device, imaging system, and moving body | CANON KABUSHIKI KAISHA (JP) | 2025-03-04 | — | — | US | disclosed |
| EP-3859804-B1 | SEMICONDUCTOR DEVICE HAVING QUANTUM DOTS | CANON KK (JP) | 2024-08-07 | — | — | EP | disclosed |
| CN-113285024-A | Semiconductor device having quantum dots, display device, imaging system, and moving object | 佳能株式会社 | 2021-08-20 | — | — | CN | disclosed |
| US-20210242416-A1 | SEMICONDUCTOR DEVICE HAVING QUANTUM DOTS, DISPLAY DEVICE, IMAGING SYSTEM, AND MOVING BODY | CANON KABUSHIKI KAISHA (JP) | 2021-08-05 | — | — | US | disclosed |
| EP-3859804-A2 | SEMICONDUCTOR DEVICE HAVING QUANTUM DOTS | CANON KABUSHIKI KAISHA (JP) | 2021-08-04 | — | — | EP | disclosed |
| CN-102917590-B | Tricyclic compound and the PBK inhibitor containing described compound | ONCOTHERAPY SCIENCE, INC. (JP) | 2016-02-17 | — | — | CN | disclosed |
| CN-104844578-A | 5-MEMBERED HETEROCYCLIC AMIDES AND RELATED COMPOUNDS | NEUROGEN CORP | 2015-08-19 | — | — | CN | disclosed |
| CN-104804017-A | Oxazolidinone compound, and applications thereof in field of pharmacology | GUANGDONG HEC PHARMACEUTICAL | 2015-07-29 | — | — | CN | disclosed |
| CN-103687856-B | A novel 1,2,3,4-tetrahydroquinoline derivative useful for the treatment of diabetes | LILLY CO ELI | 2015-07-22 | — | — | CN | disclosed |
| CN-1262551-C | Substituted oxazolidinones and their use in the field of blood coagulation | BAYER AG (DE) | 2006-07-05 | — | — | CN | disclosed |
| CN-1772751-A | Substituted oxazolidinones and their use in the field of blood coagulation | BAYER AG (DE) | 2006-05-17 | — | — | CN | disclosed |
| CN-1253441-C | Protease inhibitors | SMITHKLINE BEECHAM CORP (US) | 2006-04-26 | — | — | CN | disclosed |
| CN-1729175-A | Tetrahydroquinoline derivatives | AKZO NOBEL NV (NL) | 2006-02-01 | — | — | CN | disclosed |
| CN-1199956-C | Oxadiazole derivs. having anticancer effects | SHIONOGI & CO (JP) | 2005-05-04 | — | — | CN | disclosed |
| CN-1436179-A | Oxadiazole derivatives having anticancer effect | SHIONOGI & CO (JP) | 2003-08-13 | — | — | CN | disclosed |
| CN-1434822-A | Substituted oxazolidinones and their use in the field of blood coagulation | BAYER AG (DE) | 2003-08-06 | — | — | CN | disclosed |
| CN-1321154-A | Propanolamine derivs. substd. with heteocyclic compound, methods for their production, pharmaceutical compositions contg. said compounds and use thereof | AVENTIS PHARMA GMBH (DE) | 2001-11-07 | — | — | CN | disclosed |
| EP-0963981-A1 | Biaryl heterocyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses thereof | Galderma Research & Development, S.N.C. (FR) | 1999-12-15 | — | — | EP | disclosed |